Bio-thera Solutions, Ltd. Class ASSE: 688177

Announcement on Marketing Authorization Approval of Gotenfia (Golimumab Injection) by European Medicines Agency (EMA)

· Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange
Announcement on Marketing Authorization Approval of Gotenfia (Golimumab Injection) by European Medicines Agency (EMA)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis